会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PROCESS TO CONTROL PARTICLE SIZE
    • 控制颗粒尺寸的过程
    • WO2007053904A1
    • 2007-05-18
    • PCT/AU2006/001687
    • 2006-11-10
    • ALPHAPHARM PTY LTDKERAMIDAS, Panagiotis (Peter)MOONEY, Dr Brett, Antony
    • MOONEY, Dr Brett, Antony
    • A61K9/00A61K9/14A61K9/20A61J3/02
    • A61K9/14
    • A multi-stage process to control the particle size of a pharmaceutical substance comprising the steps of: passing the pharmaceutical substance through a first stage of a particle size reduction process with a first set of particle size control parameters to obtain a feedstock of reduced median particle size and lesser distribution of median particle size for a second stage of a particle size reduction process; passing the feedstock, through a second stage of a particle size reduction process with a second set of particle size control parameters; optionally, using the product of the second stage or subsequent stages as a feedstock in further stages of a multi-stage particle size reduction process with a set of particle size control parameters for each stage; and collecting a pharmaceutical substance with a median particle size greater than 10µm and with a narrow, reproducible distribution of median particle sizes.
    • 用于控制药物物质的粒径的多阶段方法包括以下步骤:使第一组粒度控制参数通过药物物质通过第一阶段的粒度降低过程,以获得减少的中值粒子的原料 颗粒尺寸减小过程的第二阶段的中值粒度的大小和较小的分布; 使原料通过具有第二组粒度控制参数的粒径减小过程的第二阶段; 任选地,使用第二阶段或后续阶段的产物作为进料,在多阶段粒径减小过程的进一步阶段中,每一阶段具有一组粒度控制参数; 并收集中值粒径大于10μm的药物物质,并具有中等粒径的可重复分布。